SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-025839
Filing Date
2018-04-23
Accepted
2018-04-23 16:31:31
Documents
2
Period of Report
2018-04-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1644
2 POA DOCUMENT poa.txt EX-24.3_784732 2211
  Complete submission text file 0001209191-18-025839.txt   5593
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Issuer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KALOBIOS PHARMACEUTICALS, INC. 260 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Joseph Donald (Reporting) CIK: 0001319460 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33004 | Film No.: 18769218